Boston Scientific Corp.

XNYSHealth care

Last traded price · USD

$45.76

+5.20%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: $44.81
Previous close: $43.50
Volume: 34.6M
Day's high: $46.97
Day's low: $44.76

In brief

Boston Scientific Corp. is a health care company listed on the New York Stock Exchange, valued at about $66.32B.
Its shares closed at $45.82 on 4 Nov 2026, down 53.6% over the past year.
From India you can buy BSX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Boston Scientific Corp. (BSX) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole BSX share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade BSX options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +8.6% (SPY −1.6%, XLV +13.5%). 3 months: −4.0% (SPY −0.4%, XLV +15.5%). 1 year: −53.6% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BSX, SPY and XLV · as of 4 Nov 2026
15.8% above its 52-week low
Closed at $45.82 on 4 Nov 2026: 56.6% below the 52-week high of $105.65 (13 Nov 2025) and 15.8% above the low of $39.57 (28 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $45.82 was 3.0% above its 50-day average ($44.48) and 17.9% below its 200-day average ($55.84). It has closed below the 200-day for 243 sessions, since 17 Nov 2025. The 50-day average crossed below the 200-day on 16 Oct 2025, 264 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Volume 1.9× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 34.6M shares was 1.9× the average of the 30 sessions before it (18.5M), as the price rose 5.3%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Short interest at 2.8% of shares outstanding
40.7M shares were sold short at the 15 Oct 2026 settlement, 2.8% of the 1.45B shares outstanding; covering them would take 2.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+8.6%

6 months−18.2%

1 year−53.6%

5 years+7.8%

Newswire

About

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Website

Notable moves

May 27, 2026
−12.46%
March 30, 2026
−9.02%
February 4, 2026
−17.59%

Boston Scientific Corp.

XNYSHealth care

Last traded price · USD

$45.76

+5.20%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: $44.81
Previous close: $43.50
Volume: 34.6M
Day's high: $46.97
Day's low: $44.76

In brief

Boston Scientific Corp. is a health care company listed on the New York Stock Exchange, valued at about $66.32B.
Its shares closed at $45.82 on 4 Nov 2026, down 53.6% over the past year.
From India you can buy BSX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Boston Scientific Corp. (BSX) shares from India?

Do I need the price of a whole BSX share to invest?

How much can I invest in US stocks in a year?

Can I trade BSX options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +8.6% (SPY −1.6%, XLV +13.5%). 3 months: −4.0% (SPY −0.4%, XLV +15.5%). 1 year: −53.6% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BSX, SPY and XLV · as of 4 Nov 2026
15.8% above its 52-week low
Closed at $45.82 on 4 Nov 2026: 56.6% below the 52-week high of $105.65 (13 Nov 2025) and 15.8% above the low of $39.57 (28 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $45.82 was 3.0% above its 50-day average ($44.48) and 17.9% below its 200-day average ($55.84). It has closed below the 200-day for 243 sessions, since 17 Nov 2025. The 50-day average crossed below the 200-day on 16 Oct 2025, 264 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Volume 1.9× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 34.6M shares was 1.9× the average of the 30 sessions before it (18.5M), as the price rose 5.3%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Short interest at 2.8% of shares outstanding
40.7M shares were sold short at the 15 Oct 2026 settlement, 2.8% of the 1.45B shares outstanding; covering them would take 2.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+8.6%

6 months−18.2%

1 year−53.6%

5 years+7.8%

Newswire

About

Website

Notable moves

May 27, 2026
−12.46%
March 30, 2026
−9.02%
February 4, 2026
−17.59%

Boston Scientific Corp.

Boston Scientific Corp. in brief

Behind SPY and its sector fund XLV over 1 year

15.8% above its 52-week low

Above its 50-day average, below its 200-day

Volume 1.9× its 30-session average on 4 Nov 2026

Short interest at 2.8% of shares outstanding

Boston Scientific Corp.

Boston Scientific Corp. in brief

Behind SPY and its sector fund XLV over 1 year

15.8% above its 52-week low

Above its 50-day average, below its 200-day

Volume 1.9× its 30-session average on 4 Nov 2026

Short interest at 2.8% of shares outstanding